STOCK TITAN

Astrotech FY2026 sales fall to $913K, loss hits $14.4M

Year-end cash and short-term investments totaled $11.3 million, which Astrotech believes will support operating expenses and capital expenditure requirements.

(Very High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Astrotech Corporation (ASTC) reported fiscal 2026 results for the year ended June 30, 2026. Revenue was $913,000, compared with $1,049,000 in fiscal 2025. Gross profit was $217,000 versus $475,000, and net loss was $14.427 million versus $13.850 million. Total operating expenses were $14.355 million, compared with $15.209 million in fiscal 2025; the company’s highlights characterized expenses as $14 million, down 6%.

At June 30, 2026, cash and cash equivalents and short-term investments totaled $11.3 million, which the company believes will support operating expenses and capital expenditure requirements. Astrotech said it launched lunar resource and infrastructure strategic initiatives and is focused on converting pipeline opportunities into revenue growth. Its Lunar Power and Light subsidiary was focused on potentially developing lunar-surface infrastructure for semiconductor processing, advanced computing systems, and quantum-computing manufacturing. The contemplated lunar energy-storage application remains in evaluation and development. EN-SCAN delivers portable environmental testing solutions integrating gas chromatography and mass spectrometry.

Positive

  • None.

Negative

  • Revenue was $913,000, down from $1,049,000 in fiscal 2025.

Filing Explained

Astrotech’s fiscal-year balance sheet reports 1,998,734 common shares outstanding at June 30, 2026, versus 1,758,953 a year earlier. That larger share base reduces an existing holder’s percentage ownership absent offsetting changes.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Revenue $913,000 Fiscal year ended June 30, 2026; $1,049,000 in fiscal 2025
Gross profit $217,000 Fiscal year ended June 30, 2026; $475,000 in fiscal 2025
Total operating expenses $14.355 million Fiscal year ended June 30, 2026; $15.209 million in fiscal 2025
Net loss $14.427 million Fiscal year ended June 30, 2026; $13.850 million in fiscal 2025
Cash and cash equivalents and short-term investments $11.3 million As of June 30, 2026
mass spectrometry technical
"Astrotech is a mass spectrometry company"
Mass spectrometry is a laboratory technique that identifies and measures chemicals by giving molecules an electrical charge and sorting them by how fast they move, like weighing and separating coins to see which kinds are present. For investors, its results are evidence used in drug development, quality control, food and environmental testing, and diagnostics, so clear mass-spec data can affect regulatory approval, product reliability, costs and market confidence.
gas chromatography technical
"integrate gas chromatography and mass spectrometry"
An analytical lab method that separates and measures the different chemical components in a gas or volatile liquid sample, like sorting runners by speed on a racetrack so each can be identified and counted. Investors care because results from gas chromatography verify product purity, safety and regulatory compliance, detect contaminants or quality problems that can trigger recalls or fines, and influence production costs and market trust.
available-for-sale securities financial
"Available-for-sale securities"
Available-for-sale securities are investments in stocks, bonds or similar instruments that a company does not intend to trade frequently but may sell before they mature. They matter to investors because changes in the market value of these holdings show up as paper gains or losses on the company's balance sheet rather than immediately in profit, so they can affect reported net worth and the timing of income without changing day-to-day earnings. Think of them like items on a household shelf you might sell later: their value moves with the market even if you haven’t cashed out.
operating lease right-of-use assets financial
"Operating lease right-of-use assets, net"
An operating lease right-of-use (ROU) asset is an accounting entry that shows the value of a leased item you have the legal right to use—like a building, vehicle, or equipment—recorded on a company’s balance sheet along with the corresponding lease obligation. Investors care because it adds to reported assets and liabilities, changing measures like leverage and return on assets much like bringing a long-term rental onto the company’s financial snapshot, which can affect credit terms and valuation.
Revenue $913,000 Compared with $1,049,000 in fiscal 2025
Gross profit $217,000 Compared with $475,000 in fiscal 2025
Total operating expenses $14.355 million Compared with $15.209 million in fiscal 2025
Net loss $14.427 million Compared with $13.850 million in fiscal 2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What revenue did ASTC report for fiscal 2026?

Astrotech reported revenue of $913,000 for the fiscal year ended June 30, 2026, compared with $1,049,000 in fiscal 2025. Gross profit was $217,000 versus $475,000, and net loss was $14.427 million versus $13.850 million.

How much cash did ASTC have at June 30, 2026?

Astrotech reported $11.3 million in cash and cash equivalents and short-term investments as of June 30, 2026. The company said it believes this amount will support operating expenses and capital expenditure requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001001907 0001001907 2026-09-25 2026-09-25
 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): September 25, 2026
 
logo.jpg
 
Astrotech Corporation
 
(Exact Name of Registrant as Specified in Charter)
 
Delaware
 
001-34426
 
91-1273737
(State or Other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
1817 W. Braker Ln. Ste. 400, Austin, Texas
 
78758
(Address of Principal Executive Offices)
 
(Zip Code)
 
(512) 485-9530
Registrant’s Telephone Number, Including Area Code
 
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
☐
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on which registered
Common Stock, $0.001 par value per share
 
ASTC
 
NASDAQ Stock Market, LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 
Item 2.02. Results of Operations and Financial Condition.
 
On September 25, 2026, Astrotech Corporation (the “Company”) issued a press release announcing its results of operations for the quarter and year ended June 30, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
 
The information in this Current Report on Form 8-K, including Exhibit 99.1 furnished hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth in such filing.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits
 
Exhibit 
No.
 
Description
99.1
 
Press Release, dated September 25, 2026, issued by Astrotech Corporation (furnished pursuant to Item 2.02).
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document).
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Astrotech Corporation
 
 
 
September 25, 2026
By:
/s/ Thomas B. Pickens III
 
 
Thomas B. Pickens III
 
 
Chief Executive Officer, Chief Technology Officer and Chairman of the Board
 
 

Exhibit 99.1

 

ex_1019391img001.jpg

 

 

ASTROTECH REPORTS FISCAL YEAR 2026 FINANCIAL RESULTS

 

Austin, Texas – September 25, 2026 – Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2026.

 

Financial Highlights & Fiscal Year Developments 

 

 

 

●

As of June 30, 2026, the Company had deployed the TRACER 1000 in approximately 37 locations in 16 countries across the United States, Europe and Asia.

 

 

●

The Company launched its Labrador ruggedized Handheld Gas Chromatograph designed to bring laboratory-grade volatile organic compound analysis directly to the point of investigation.

 

 

●

The Board of Directors of the Company approved a strategic initiative focused on potential future lunar resource development, autonomous lunar industrial infrastructure, Moon based advanced computing, semiconductor, manufacturing, lunar power generation and power infrastructure, mining, chemical manufacturing, product transportation and equipment leasing opportunities on the Moon through its newly formed subsidiary, Lunar Power and Light Corporation. As part of the initiative, Astrotech intends to evaluate and potentially develop infrastructure technologies that could support semiconductor processing, advanced computing systems, and quantum computing manufacturing operations on the lunar surface.

 

 

●

Total operating expenses were $14 million, a decline of 6% during the fiscal year ended June 30, 2026, compared to the fiscal year ended June 30, 2025.

 

 

 

 

●

Astrotech’s consolidated balance sheet consisted of $11.3 million in cash and cash equivalents and short-term investments as of June 30, 2026, which the Company believes will support operating expenses and capital expenditure requirements.

 

“Our fiscal year 2026 results reflect an important period of investment and progress. We have advanced several priorities that strengthen the foundation for scalable growth, including the launch of our new lunar resource and infrastructure strategic initiatives. We believe these initiatives could expand our addressable opportunities and position us to better serve customers over the long term. We enter the new year focused on executing on these opportunities with the goal of converting pipeline opportunities into revenue growth,” stated Thomas B. Pickens, III, Astrotech’s Chairman, Chief Executive Officer and Chief Technology Officer. 

 

About Astrotech Corporation

 

Astrotech (Nasdaq: ASTC) is a mass spectrometry company that creates, operates, and scales innovative businesses through its wholly owned subsidiaries. Each subsidiary leverages Astrotech’s core technology to serve specialized markets:

 

 

●

1st Detect develops, manufactures, and markets trace detection systems for security and narcotics screening applications.

 

●

AgLAB designs process analyzers tailored to the agriculture industry.

 

●

Pro-Control produces solutions for in-situ chemical process control in industrial manufacturing.

 

●

EN-SCAN, Inc. delivers portable, ruggedized environmental testing solutions that integrate gas chromatography and mass spectrometry for use in challenging field environments.

 

●

Lunar Power and Light focused on potentially developing infrastructure technologies that could support semiconductor processing, advanced computing systems, and quantum computing manufacturing operations on the lunar surface.

 

Astrotech is headquartered in Austin, Texas. For more information, visit www.astrotechcorp.com

 


 

Forward-Looking Statements

 

This press release contains “forward-looking statements” that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These statements may be identified by terms such as “aims,” “anticipates,” “believes,” “contemplates,” “continue,” “could,” “estimates,” “expect,” “forecast,” “guidance,” “intends,” “may,” “plans,” “possible,” “potential,” “predicts,” “preliminary,” “projects,” “seeks,” “should,” “targets,” “will” or “would,” or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements include, but are not limited to, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars in Ukraine and the middle east, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, the Company’s lunar infrastructure initiatives, potential NASA selection, funding, awards or contracts, technology development, partnerships, autonomous systems, lunar resource mining and processing, advanced manufacturing, power development, artificial intelligence, quantum computing, advanced semiconductor materials and commercial lunar activity, future engineering and testing, technology qualification, commercialization and potential lunar resource deployment and long-duration energy storage; and the Company's ability to finance, validate, launch, operate or commercialize related systems, and the potential effects of the addition of advisors, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. 

 

Any forward-looking statements in this document should be evaluated in light of these important risk factors. The contemplated lunar energy-storage application remains in the evaluation and development stage. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward- looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

 

 

Company Contact: 

Scott Bartley

Interim Chief Financial Officer, Astrotech Corporation

(512) 485-9530

 

 

Tables follow

 


 

ASTROTECH CORPORATION

Consolidated Statements of Operations and Other Comprehensive Loss

(In thousands, except per share data)

 

​

​

June 30,

​

​

​

2026

​

​

2025

​

Revenue

​

$

913

​

​

$

1,049

​

Cost of revenue

​

​

696

​

​

​

574

​

Gross profit

​

​

217

​

​

​

475

​

Operating expenses:

​

​

​

​

​

​

​

​

Selling, general and administrative

​

​

7,871

​

​

​

7,067

​

Research and development

​

​

6,484

​

​

​

8,142

​

Total operating expenses

​

​

14,355

​

​

​

15,209

​

Loss from operations

​

​

(14,138

)

​

​

(14,734

)

Interest and dividend income

​

​

471

​

​

​

1094

​

Realized loss

​

​

(543

)

​

​

(5

)

Other income and expense, net

​

​

(213

)

​

​

(203

)

Total other income(expense)

​

​

(285

)

​

​

886

​

Loss from operations before income taxes

​

​

(14,423

)

​

​

(13,848

)

Income tax benefit /(expense)

​

​

(4

)

​

​

(2

)

Net loss

​

$

(14,427

)

​

$

(13,850

)

Weighted average common shares outstanding:

​

​

​

​

​

​

​

​

Basic and diluted

​

​

1,700

​

​

​

1,665

​

Basic and diluted net loss per common share:

​

​

​

​

​

​

​

​

Net loss per common share

​

$

(8.49

)

​

$

(8.32

)

Other comprehensive loss, net of tax:

​

​

​

​

​

​

​

​

Net loss

​

$

(14,427

)

​

$

(13,850

)

Available-for-sale securities:

​

​

​

​

​

​

​

​

Net unrealized gain

​

​

548

​

​

​

313

​

Total comprehensive loss

​

$

(13,879

)

​

$

(13,537

)

 

 


 

ASTROTECH CORPORATION

Consolidated Balance Sheets

(In thousands, except share and per share data)

 

​

​

June 30,

​

​

​

2026

​

​

2025

​

Assets

​

​

​

​

​

​

​

​

Current assets

​

​

​

​

​

​

​

​

Cash and cash equivalents

​

$

8,387

​

​

$

3,100

​

Short-term investments

​

​

2,947

​

​

​

15,108

​

Accounts receivable

​

​

124

​

​

​

485

​

Inventory, net:

​

​

​

​

​

​

​

​

Raw materials

​

​

2,926

​

​

​

2,194

​

Work-in-process

​

​

9

​

​

​

425

​

Finished goods

​

​

1,179

​

​

​

310

​

Prepaid expenses and other current assets

​

​

354

​

​

​

353

​

Total current assets

​

​

15,926

​

​

​

21,975

​

Property and equipment, net

​

​

2,383

​

​

​

2,395

​

Intangible assets, net

​

​

50

​

​

​

48

​

Operating lease right-of-use assets, net

​

​

1,834

​

​

​

2,225

​

Other assets, net

​

​

314

​

​

​

346

​

Total assets

​

$

20,507

​

​

$

26,989

​

Liabilities and stockholders’ equity

​

​

​

​

​

​

​

​

Current liabilities

​

​

​

​

​

​

​

​

Accounts payable

​

$

581

​

​

$

1,066

​

Payroll related accruals

​

​

482

​

​

​

529

​

Accrued expenses and other liabilities

​

​

912

​

​

​

451

​

Lease liabilities, current

​

​

282

​

​

​

405

​

Total current liabilities

​

​

2,257

​

​

​

2,451

​

Accrued expenses and other liabilities, net of current portion

​

​

54

​

​

​

164

​

Lease liabilities, net of current portion

​

​

2,024

​

​

​

2,274

​

Total liabilities

​

​

4,335

​

​

​

4,889

​

Commitments and contingencies (Note 14)

​

​

​

​

​

​

​

​

Stockholders’ equity

​

​

​

​

​

​

​

​

Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series D issued and outstanding at June 30, 2026 and 2025, respectively

​

​

—

​

​

​

—

​

Common stock, $0.001 par value, 250,000,000 shares authorized at June 30, 2026 and 2025 respectively; 2,009,050 and 1,769,269 shares issued at June 30, 2026 and 2025 respectively; 1,998,734 and 1,758,953 outstanding at June 30, 2026 and 2025, respectively

​

​

190,643

​

​

​

190,643

​

Treasury shares, 10,316 shares at June 30, 2026 and 2025, respectively

​

​

(119

)

​

​

(119

)

Additional paid-in capital

​

​

91,261

​

​

​

83,310

​

Accumulated deficit

​

​

(265,297

)

​

​

(250,870

)

Accumulated other comprehensive loss

​

​

(316

)

​

​

(864

)

Total stockholders’ equity

​

​

16,172

​

​

​

22,100

​

Total liabilities and stockholders’ equity

​

$

20,507

​

​

$

26,989

​

 

 

Filing Exhibits & Attachments

5 documents

Keep reading